Acuvu Completed 100 Million RMB in Series B Financing to Promote Innovation in Disposable Endoscope Products and Accelerate Global Distribution
Sept 4, 2021
Suzhou Acuvu Medical Technology Co., Ltd. recently announced the completion of B round of financing of over 100 million RMB. The investment was jointly led by CITIC Medical Fund and Changan Private Capital, with Gelu Capital acting as the exclusive financial advisor. This round of financing will be mainly used to promote the marketing of the company's single-use hysteroscopy diagnosis and treatment platform and the development and registration of a variety of innovative endoscopic products.
Acuvu is a medical device company focusing on disposable endoscopes. It is committed to promoting women's health through innovative medical device products and being a leader in overall solutions in the field of minimally invasive gynecology. The company established a global strategy at the beginning of its establishment. It was founded in 2017 in Silicon Valley, USA, and set up a research and development center, which is mainly engaged in cutting-edge technology exploration and innovative product development. At the end of 2018, Suzhou Acuvu Medical Technology Co., Ltd. was established in Suzhou as the main body of late-stage product development and production. Acuvu's disposable hysteroscope series products have completed the US FDA 510K registration, and are expected to be marketed and sold in the European and American markets in the near future. In China, Acuvu products have completed the product type inspection report and are expected to become the first batch of certified disposable hysteroscopy products in China.